Grove Biopharma
PrivateLast Round
Series A
Apr 23, 2025
Total Funding Raised
$34.25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Grove Biopharma is a biotechnology company that develops novel therapeutics targeting intracellular protein-protein interactions using its proprietary Bionic Biologics™ platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grove Biopharma Comparables
Compare Grove Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Libera Bio | 75% | |
| Dunad Therapeutics | 73% | |
| C4 Therapeutics | 69% |
Grove Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 23, 2025 | ||||
| Grant | Jul 15, 2023 | ||||
| Seed | May 10, 2021 |
Key People
Founding team and executive leadership
Grove Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| DCVC Bio | Series A |
| InVivium Capital | Series A |
| Mansueto Office | Series A |
| Walder Ventures | Seed, Series A |
| Skydeck Capital | Seed |
| Portal Innovations | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 39% MoM, reaching 1.8K.
- Jul 27, 2026
Grew 25% QoQ, from 24 to 30 employees.
Grove Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Grove Biopharma's valuation, stock price, and market status.
Is Grove Biopharma a public or private company?
Grove Biopharma is a private company.
What is the current stock price of Grove Biopharma?
Grove Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is Grove Biopharma worth (valuation)?
Valuation information for Grove Biopharma is not publicly available.
Can I buy Grove Biopharma stock?
Grove Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Grove Biopharma's last funding round?
Grove Biopharma's most recent funding round was Series A on April 23, 2025.
Who are the main investors in Grove Biopharma?
Key investors in Grove Biopharma include DCVC Bio, Portal Innovations.
Will Grove Biopharma IPO soon?
No public IPO plans have been announced for Grove Biopharma.
How can I track Grove Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Grove Biopharma's secondary market activity and sign up for updates.